Bezzina G, Body S, Cheung T H C, Hampson C L, Bradshaw C M, Glennon J C, Szabadi E
Psychopharmacology Section, Division of Psychiatry, University of Nottingham, Medical School, Nottingham, NG7 2UH, UK.
Psychopharmacology (Berl). 2015 Feb;232(4):699-711. doi: 10.1007/s00213-014-3700-5. Epub 2014 Aug 19.
5-Hydroxytryptamine2C (5-HT2C) receptor agonists reduce the breakpoint in progressive ratio schedules of reinforcement, an effect that has been attributed to a decrease of the efficacy of positive reinforcers. However, a reduction of the breakpoint may also reflect motor impairment. Mathematical models can help to differentiate between these processes.
The effects of the 5-HT2C receptor agonist Ro-600175 ((αS)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine) and the non-selective 5-HT receptor agonist 1-(m-chlorophenyl)piperazine (mCPP) on rats' performance on a progressive ratio schedule maintained by food pellet reinforcers were assessed using a model derived from Killeen's Behav Brain Sci 17:105-172, 1994 general theory of schedule-controlled behaviour, 'mathematical principles of reinforcement'.
Rats were trained under the progressive ratio schedule, and running and overall response rates in successive ratios were analysed using the model. The effects of the agonists on estimates of the model's parameters, and the sensitivity of these effects to selective antagonists, were examined.
Ro-600175 and mCPP reduced the breakpoint. Neither agonist significantly affected a (the parameter expressing incentive value), but both agonists increased δ (the parameter expressing minimum response time). The effects of both agonists could be attenuated by the selective 5-HT2C receptor antagonist SB-242084 (6-chloro-5-methyl-N-{6-[(2-methylpyridin-3-yl)oxy]pyridin-3-yl}indoline-1-carboxamide). The effect of mCPP was not altered by isamoltane, a selective 5-HT1B receptor antagonist, or MDL-100907 ((±)2,3-dimethoxyphenyl-1-(2-(4-piperidine)methanol)), a selective 5-HT2A receptor antagonist.
The results are consistent with the hypothesis that the effect of the 5-HT2C receptor agonists on progressive ratio schedule performance is mediated by an impairment of motor capacity rather than by a reduction of the incentive value of the food reinforcer.
5-羟色胺2C(5-HT2C)受体激动剂可降低渐进比率强化程序中的断点,这一效应被认为是由于阳性强化物效力降低所致。然而,断点的降低也可能反映运动功能受损。数学模型有助于区分这些过程。
使用源自基林1994年发表于《行为脑科学》第17卷第105 - 172页的“强化的数学原理”这一程序控制行为一般理论的模型,评估5-HT2C受体激动剂Ro-600175((αS)-6-氯-5-氟-α-甲基-1H-吲哚-1-乙胺)和非选择性5-HT受体激动剂1-(间氯苯基)哌嗪(mCPP)对大鼠在由食物颗粒强化维持的渐进比率程序中的表现的影响。
大鼠在渐进比率程序下接受训练,并使用该模型分析连续比率中的奔跑和总体反应率。研究了激动剂对模型参数估计值的影响,以及这些影响对选择性拮抗剂的敏感性。
Ro-600175和mCPP降低了断点。两种激动剂均未显著影响a(表示激励值的参数),但两种激动剂均增加了δ(表示最小反应时间的参数)。两种激动剂的作用均可被选择性5-HT2C受体拮抗剂SB-242084(6-氯-5-甲基-N-{6-[(2-甲基吡啶-3-基)氧基]吡啶-3-基}吲哚啉-1-甲酰胺)减弱。mCPP的作用未被选择性5-HT1B受体拮抗剂异戊烷或选择性5-HT2A受体拮抗剂MDL-100907((±)2,3-二甲氧基苯基-1-(2-(4-哌啶)甲醇)改变。
结果与以下假设一致,即5-HT2C受体激动剂对渐进比率程序表现的影响是由运动能力受损介导的,而非食物强化物激励值的降低。